Dermal undifferentiated pleomorphic sarcoma C49.-

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 07.03.2024

Dieser Artikel auf Deutsch

Synonym(s)

Fibroxanthosarcoma; malignant fibrous histiocytoma; MFH; Pleomorphic sarcoma undifferentiated; Sarcoma dermal undifferentiated pleomorph; Undifferentiated pleomorphic sarcoma; UPS

Definition
This section has been translated automatically.

Malignant fibrohistiocytic tumor that belongs to a small group of tumors that were formerly called malignant fibrous histiocytomas. UPS is one of the most common soft tissue sarcomas in adults.

Occurrence/Epidemiology
This section has been translated automatically.

Reliable incidence rates are not available. m:w=1.2:1

Etiopathogenesis
This section has been translated automatically.

The UPS is the de-differentiated form of many soft tissue tumors. The former histiocytic term pleomorphic MFH only applies to those UPS forms for which no differentiation direction (fibroblastic, myofibroblastic) can be demonstrated.

Manifestation
This section has been translated automatically.

Middle and higher age: >40 years

Localization
This section has been translated automatically.

Dermal undifferentiated pleomorphic sarcomas of the skin can preferably be found just like AFX in actinic damaged skin of older patients.

Clinical features
This section has been translated automatically.

Large, deep-seated, coarse, varying in size, hardly painful, rapidly growing nodules and tumour masses (size up to 20 cm in diameter), which have a tendency to early metastasis. 5% of patients already have metastases at diagnosis.

Histology
This section has been translated automatically.

  • Very heterogeneous tumour masses, very rich in cells or with a high proportion of connective tissue, with conspicuous cytological and nuclear pleomorphism. Bizarre tumor giant cells, spindle cells (fibroblastic, myofibroblastic or smooth muscle) and round histiocyte-like cells are also found. A storiform growth pattern can be detected in sections. Furthermore inflammatory infiltrate cells.
  • Immunohistochemistry: Most UPS show a definable differentiation. Immunohistochemistry is mainly concerned with finding a differentiation from non-mesenchymal malignant tumors.
  • Molecular pathology: The karyotypes of UPS are very complex and heterogeneous. Aneuploidy is frequent. Loss of 2p24-pter, 2q32-qter, 11, 13, 16; gain of 7p15-pter, 7q32 and 1p31. Amplification of some proto-oncogenes in 12q13-15: SAS, MDM2, CDK4, DDIT3, HMGIC and 8p23.1:MASL1.
  • Detection of mutations or deletions in TP53, RB1(retinoblastoma protein - see ERK below), CDKN2A and HRAS.

Indirect immunofluorescence
This section has been translated automatically.

Immunohistochemical examination: CD10, CD68, FactorXIIIα, S100, MelanA, SOX10, CKAE1/AE3, p63, CD34

Microscopic examination: Histologically, the described tissue fragment corresponds to a tumor section without epithelial covering. In the vascular fibrous layer of the above biopsy section of the tumor, the presence of atypical pleomorphic cells, the type of atypical polygonal cells, atypical spindle cells and of atypical giant cells, some of which are multinucleated.

Immunohistochemistry: In the immunohistochemical study, the neoplastic cells are: CD10(+), CD68(+), FactorXIIIα(+), S100(-), MelanA (-), SOX10(-), CKAE1/AE3(-), p63(-), CD34(-).

Conclusion/comment: Section of a skin tumor with individual morphological and immunohistochemical elements that cannot be evaluated as pathognomonic. Among other things, in the present section of the tumor, a question of histological differential diagnosis arises mainly between the segment of atypical fibroxanthoma and the segment of pleomorphic cutaneous sarcoma.

Operative therapie
This section has been translated automatically.

After diagnosis, generous surgery in specialized centers.

Case report(s)
This section has been translated automatically.

Prognosis 5-year survival 50-60%. However, the subgroups of pleomorphic sarcomas have different prognoses. For example, liposarcoma has a metastasis rate of 15-20%, high grade myxofibrosarcoma 30-35% and pleomorphic myogenic sarcoma has a significantly higher rate. Bibliography WHO Classification: Tumours of Soft Tissue and Bone, 2002

Outgoing links (2)

Fibroxanthoma atypical; Hras;

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 07.03.2024